Economic analysis of lenograstim in the correction of neutropenia following chemotherapy for non-Hodgkin's lymphoma. [electronic resource]
Producer: 19951129Description: 36-43 p. digitalISSN:- 1170-7690
- Adjuvants, Immunologic -- economics
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Chemotherapy, Adjuvant
- Double-Blind Method
- Female
- France
- Granulocyte Colony-Stimulating Factor -- economics
- Hospitalization -- economics
- Humans
- Lenograstim
- Lymphoma, Non-Hodgkin -- complications
- Male
- Middle Aged
- Neutropenia -- chemically induced
- Prospective Studies
- Recombinant Proteins -- economics
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.